Over the 2021–2024 period Molina Healthcare’s balance sheet shows steady growth in scale with assets rising from $12,209m to $15,630m (an increase of $3,421m, or ~28%). The largest one-year expansion occurred between 2022 and 2023 when assets jumped about 21% (roughly $2,578m). Liabilities also increased, but more modestly — from $9,579m to $11,134m (+$1,555m, or ~16%) — so the company’s absolute leverage rose but at a slower pace than assets. Because equity grew much faster than liabilities (from $2,630m to $4,496m, up $1,866m or ~71%), capitalization improved noticeably: the equity-to-assets ratio rose from ~21.5% in 2021 to ~28.7% in 2024 while the liabilities-to-assets ratio fell from ~78.5% to ~71.3%. The big 2022→2023 step in equity (≈+42%) is particularly noteworthy and may reflect strong retained earnings, capital transactions, or balance-sheet effects (e.g., acquisitions or reserve movements) common in the managed-care/Medicaid insurer space. The 2025 row contains zeros and appears to be missing data; review the company’s filings/notes to confirm drivers of the 2023 jump and the composition of the asset and liability increases for a fuller risk/solvency assessment.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.